Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer.

Raabe, Nils; Sauer, T; Erichsen, A; Jm, Nesland; Fossaa, S. D.

doi:10.3892/or.6.5.1001

Cited by 6 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the remaining 8 cases, clinical criteria were conclusive in 4, whereas all 8 cases were classified successfully by partial allelotyping, with concordance with the assessment using clinical criteria. Similar findings were implied in a largescale study 20 in which 66% of the second breast carcinomas were shown to be of a differing histotype, indicating at least 66% of the tumors as distinct primary tumors. Our study provides evidence at the genomic level of the epidemiologic observation that the eventual outcome and prognosis for patients with bilateral mammary carcinomas were similar to those for unilateral disease, 21,22 implying a new primary tumor rather than a much later staged distant organ metastasis.…”

Section: Discussionsupporting

confidence: 85%

Clonal Analysis of Bilateral Mammary Carcinomas by Clinical Evaluation and Partial Allelotyping

et al. 2003

View full text Add to dashboard Cite

Bilateral breast carcinomas may represent contralateral metastases or new primary tumors. The presence of carcinoma in situ, a lower grade, or a different histotype in the second tumor is considered a clinical criterion for a second primary tumor. In this study, 26 bilateral breast carcinomas from 13 patients were analyzed based on clinical criteria, and the results were compared with those obtained by partial allelotyping using 47 markers at 7 chromosomal arms. Of the 8 synchronous tumors, 5 were concluded to be distinct primary tumors using clinical criteria; some were confirmed by partial allelotyping. In the remaining 3 cases, partial allelotyping showed distinct primary tumors. Five patients had metachronous carcinomas with 3 distinct primary tumors, 1 metastasis, and 1 that was uncertain by clinical criteria. Three cases were confirmed by partial allelotyping, and the uncertain case was shown to be distinct primary tumors. No discrepant results were noted. Stringent application of clinical criteria is accurate for differentiating second primary tumors from metastases.

show abstract

Section: Discussionsupporting

confidence: 85%

Clonal Analysis of Bilateral Mammary Carcinomas by Clinical Evaluation and Partial Allelotyping

et al. 2003

View full text Add to dashboard Cite

show abstract

“…When there is cancer in one breast, the potential risk that cancer will be found in the contralateral breast in the future is not great, but it still exists, and we cannot ignore it. The likelihood that breast cancer will appear in the contralateral side is 6% after 10 years and 9% after 20 years 13 14 15 16 . Therefore, a surgeon should explain this possibility to patients and evaluate the opposite breast for cancer development properly by regular physical examinations, mammography, and magnetic resonance imaging before surgery 17 .…”

Section: Discussionmentioning

confidence: 99%

Selection of Implants in Unilateral Prosthetic Breast Reconstruction and Contralateral Augmentation

et al. 2017

View full text Add to dashboard Cite

BackgroundIn breast reconstruction using implants after unilateral mastectomy, it is challenging to create a natural, ptotic contour, and asymmetry is a potential drawback. To achieve breast symmetry and an ideal shape for both breasts, we performed contralateral augmentation in patients undergoing breast reconstruction with implants.MethodsPatients underwent unilateral mastectomy and 2-stage reconstruction. During the second stage of the procedure, contralateral augmentation mammoplasty was performed. Preoperatively, we obtained the patients’ demographic information, and we then assessed breast volume, the volume and dimensions of the inserted implants, and complications. Breast symmetry was observed by the surgeon and was assessed by measuring the disparity between the final volume of each breast.ResultsContralateral augmentation was performed in 52 cases. When compared to patients who did not undergo a contralateral balancing procedure, patients who received contralateral augmentation were younger, thinner, and had smaller breasts. During implant selection for contralateral augmentation, we chose implants that were approximately 1 cm shorter in width, 1 level lower in height, and 1 or 2 levels lower in projection than the implants used for reconstruction. The postoperative breast contours were symmetric and the final volume discrepancy between each breast, which was measured by 3-dimensional scanning, was acceptable.ConclusionsWe demonstrate that contralateral augmentation can be recommended for patients who perceive their breasts to be small and not beautiful in order to achieve an ideal and beautiful shape for both breasts. Furthermore, this study offers guidelines for selecting the implant that will lead to the optimal aesthetic outcome.

show abstract

Cancer du sein bilatéral. Incidence et facteurs de risque

Hanchi

Berrada

Fadli

et al. 2004

Gynécologie Obstétrique & Fertilité

View full text Add to dashboard Cite

Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer.

Cited by 6 publications

References 0 publications

Clonal Analysis of Bilateral Mammary Carcinomas by Clinical Evaluation and Partial Allelotyping

Clonal Analysis of Bilateral Mammary Carcinomas by Clinical Evaluation and Partial Allelotyping

Selection of Implants in Unilateral Prosthetic Breast Reconstruction and Contralateral Augmentation

Cancer du sein bilatéral. Incidence et facteurs de risque

Contact Info

Product

Resources

About